Search clinical trials for: ABI-2280

Total 2594 results

Celgene

Withdrawn

A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies

Solid Tumor

United States
Bayer
Titan Pharmaceuticals

Terminated

STEPS Trial - Spheramine Safety and Efficacy Study

Parkinson Disease

Spain, United States, Germany
Enzon Pharmaceuticals, Inc.

Completed

A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01)

Lymphoma | Advanced Solid Tumors

United States
Medical College of Wisconsin
National Institute on Aging (NIA)

Completed

Network-Level Mechanisms for Preclinical Alzheimer's Disease Development

APOE 4

United States
AstraZeneca
Pretium Pty Ltd

Completed

Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease (ACHILLES)

Peripheral Arterial Disease

Australia
Recursion Pharmaceuticals Inc.

Recruiting

Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas (POPLAR-NF2)

Neurofibromatosis Type 2

United States
Merck Sharp & Dohme LLC

Terminated

MK0974 (Telcagepant) for Migraine Prophylaxis in Patients With Episodic Migraine (0974-049)

Migraine
Bristol-Myers Squibb
Celgene

Completed

A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult Participants

Healthy Volunteers

United States
Jan Biziel University Hospital No 2 in Bydgoszcz

Unknown

The Prevalence of a Low Ankle-Brachial Index in Acute Cerebral Ischemia.

Ischemic Stroke

Poland
The Cleveland Clinic

Terminated

Lower Extremity Venous Hemodynamics in Obese Patients Without Clinically Significant Venous Disease

Obesity | Peripheral Arterial Disease

United States
Celgene

Withdrawn

A Phase 2 Study With CC-220 in Skin Sarcoidosis

Sarcoidosis
University Hospital, Brest

Terminated

Automation Oxygen Flow Titration in Spontaneously Breathing Infants

Bronchiolitis

France
Enzon Pharmaceuticals, Inc.

Terminated

A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer (PEG-SN38)

Metastatic Breast Cancer

United States
Celgene

Completed

Evaluate the Pharmacokinetics of CC-220 in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared With Healthy Subjects

Healthy Volunteers | Hepatic Impairment

United States
Istanbul Training and Research Hospital

Completed

Effects of Autologous Blood Injection Versus Platelet Rich Plasma on Chronic Plantar Fasciitis (PF:AutovsPRP)

Plantar Fascitis

Turkey
Bradley A. McGregor, MD
Calithera Biosciences, Inc

Completed

Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma

Renal Cell Carcinoma

United States
Celgene Corporation

Completed

3-part Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Multiple Doses of CC-220 and Relative Bioavailability of a Formulated CC-220 Capsule

Healthy Volunteers

United States
Mayo Clinic
ARYx Therapeutics

Completed

Effect of ATI-7505 on Gastrointestinal Transit in Healthy Volunteers

Healthy

United States
Yuzuncu Yıl University

Completed

Comparison of Er,Cr:YSGG and Diode Lasers In Second Stage Implant Surgery

Postoperative Pain | Wound Heal | Soft Tissue Bleeding

Turkey
AgeneBio
National Institute on Aging (NIA)

Completed

Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease (HOPE4MCI)

Mild Cognitive Impairment | Prodromal Alzheimer's Disease

United States, Canada
Merck Sharp & Dohme LLC

Completed

Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)

Migraines
Memorial Sloan Kettering Cancer Center
BMS Foundation

Recruiting

Study of Peripheral Arterial Disease (PAD) in People With Cancer Who Will Be Having Surgery

Peripheral Arterial Disease (PAD) in Cancer Patients

United States
Selayang Hospital

Completed

Review of Trend in Incidence and Characteristics of Hospital-acquired Acute Kidney Injury in Hospital Selayang (HA-AKI-HS)

Acute Kidney Injury | Acute Renal Failure | Kidney Failure, Acute | Hospital Acquired Condition

Malaysia
University of Manitoba

Active, not recruiting

Financial Coaching for Adults Living With Acquired Brain Injury

Stroke | Brain Injuries

Canada
Medtronic Endovascular

Terminated

FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia

Peripheral Artery Disease

United States
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of BEA 2180 BR in Healthy Male Volunteers

Healthy
Enzon Pharmaceuticals, Inc.

Completed

A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02)

Lymphoma | Advanced Solid Tumors

United States
University of California, Davis
United States Department of Defense

Recruiting

Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

Metastatic Nonsmall Cell Lung Cancer

United States
Assembly Biosciences

Completed

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection

Chronic Hepatitis B

Singapore, Hong Kong, Bulgaria, Moldova, Republic of, New Zealand, Romania
Assembly Biosciences

Not yet recruiting

A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection

Chronic Hepatitis B
NantBioScience, Inc.

Withdrawn

QUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas

Neoplastic Disease

United States
Chang Gung Memorial Hospital

Unknown

The Effectiveness of Improving Self-care After Counseling for the Diabetics Mellitus Foots Around Chiayi Region

Diabetic Foot | Type 2 Diabetes Mellitus With Established Diabetic Nephropathy

Taiwan
Celgene Corporation

Completed

Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer

Breast Neoplasms | Metastases, Neoplasm

United States
Lyra Therapeutics

Completed

LYR-220 for Adult Subjects With Chronic Rhinosinusitis (BEACON Study)

Chronic Sinusitis | Chronic Rhinosinusitis (Diagnosis)

United States, Australia
National Cancer Institute (NCI)

Completed

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery

Refractory Pancreatic Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2

United States
Celgene

Completed

Radiolabeled Study of CC-220 in Healthy Male Subjects

Healthy Volunteer

United States
Botanix Pharmaceuticals

Completed

A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis

Hyperhidrosis

United States
Aadi Bioscience, Inc.

Withdrawn

ABI-009 (Nab-sirolimus) in Patients With Genetically-confirmed Leigh or Leigh-like Syndrome

Leigh Syndrome
National Cancer Institute (NCI)

Active, not recruiting

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

Malignant Glioma | Recurrent Childhood Ependymoma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Solid Neoplasm | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent... and other conditions

United States, Puerto Rico
Calithera Biosciences, Inc

Completed

Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors

Advanced Solid Tumors

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Withdrawn

Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated Malignancies

Malignant Neoplasms of Female Genital Organs | Malignant Neoplasms of Lip Oral Cavity and Pharynx | Malignant Neoplasms of Digestive Organs | Malignant Neoplasms of Male Genital Organs
Seattle Children's Hospital
Aadi Bioscience, Inc.

Completed

ABI-009 (Nab-rapamycin) for Surgically-Refractory Epilepsy (RaSuRE)

Epilepsy Intractable

United States
Celgene Corporation

Completed

Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Mayo Clinic

Recruiting

Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption

Brain Tumor

United States
MedImmune LLC
Amgen

Completed

Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma

Asthma

United States, Slovakia, Israel, South Africa, Ukraine, Japan, Czechia, Hungary, Bulgaria, Serbia, Latvia, Lithuania
Enzon Pharmaceuticals, Inc.

Terminated

Study of EZN-2208 Pediatric Patients With Solid Tumors

Solid Tumors

United States
Centre for Addiction and Mental Health

Completed

Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement

Psychotic Disorders | Schizophrenia | Schizo Affective Disorder

Canada
Mayo Clinic

Completed

A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast Ca

Breast Cancer

United States
Celgene

Completed

Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma

Melanoma | Metastases

United States
Celgene Corporation

Completed

ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer

Breast Neoplasms | Metastases, Neoplasm

United States

Search clinical trials for: ABI-2280

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations